These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24199806)

  • 1. Recent advances in developing nucleic acid-based HBV therapy.
    Marimani M; Hean J; Bloom K; Ely A; Arbuthnot P
    Future Microbiol; 2013 Nov; 8(11):1489-504. PubMed ID: 24199806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D; Kim SI; Kim M; Park M
    Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis B virus replication in cultured cells and in vivo using 2'-O-guanidinopropyl modified siRNAs.
    Marimani MD; Ely A; Buff MC; Bernhardt S; Engels JW; Arbuthnot P
    Bioorg Med Chem; 2013 Oct; 21(20):6145-55. PubMed ID: 23743442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference inhibitors of hepatitis B virus.
    McCaffrey AP
    Ann N Y Acad Sci; 2009 Sep; 1175():15-23. PubMed ID: 19796073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
    Ivacik D; Ely A; Arbuthnot P
    Rev Med Virol; 2011 Nov; 21(6):383-96. PubMed ID: 21913277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting the RNA interference pathway to counter hepatitis B virus replication.
    Arbuthnot P; Carmona S; Ely A
    Liver Int; 2005 Feb; 25(1):9-15. PubMed ID: 15698393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes.
    Crowther C; Mowa MB; Ely A; Arbuthnot PB
    Antivir Ther; 2014; 19(4):363-73. PubMed ID: 24296696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs.
    Mowa MB; Crowther C; Ely A; Arbuthnot P
    Microrna; 2012; 1(1):19-25. PubMed ID: 25048086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice.
    Rauschhuber C; Xu H; Salazar FH; Marion PL; Ehrhardt A
    J Gene Med; 2008 Aug; 10(8):878-89. PubMed ID: 18470951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
    Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
    Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing prospects for the future of using gene therapy to treat infections with hepatitis B virus and hepatitis C virus.
    Ely A; Arbuthnot P
    Discov Med; 2015 Sep; 20(109):137-43. PubMed ID: 26463095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities for treating chronic hepatitis B and C virus infection using RNA interference.
    Arbuthnot P; Longshaw V; Naidoo T; Weinberg MS
    J Viral Hepat; 2007 Jul; 14(7):447-59. PubMed ID: 17576386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
    Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF
    Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles.
    Chattopadhyay S; Ely A; Bloom K; Weinberg MS; Arbuthnot P
    Biochem Biophys Res Commun; 2009 Nov; 389(3):484-9. PubMed ID: 19733548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
    Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [RNA interference inhibits replication and expression of hepatitis B virus in mice].
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):630-4. PubMed ID: 15949363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in use of gene therapy to treat hepatitis B virus infection.
    Bloom K; Ely A; Arbuthnot P
    Adv Exp Med Biol; 2015; 848():31-49. PubMed ID: 25757614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advance in research of anti-HBV and anti-HCV through RNAi].
    Cai DC; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):126-8. PubMed ID: 14980131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.